BioSpace News Archive

Press Releases

Invivyd Announces U.S. FDA Has Updated the PEMGARDA™ EUA Fact Sheet with Accurate SARS-CoV-2 Variant Susceptibility and PEMGARDA Activity Data

October 1, 2024
·
12 min read
Press Releases

Kailera Therapeutics Launches with $400 Million Series A Financing to Advance Portfolio of Next-Generation Therapies for Obesity and Related Conditions

October 1, 2024
·
5 min read
Press Releases

Foghorn Therapeutics to Participate in the BMO Oncology Summit

October 1, 2024
·
1 min read
Press Releases

Eyenovia Announces Commencement of Manufacturing of its Advanced, Second Generation Optejet Device

October 1, 2024
·
4 min read
Press Releases

ORYZON receives minutes from End-of-Phase II meeting with the FDA on the PORTICO-2 Phase III vafidemstat trial in Borderline Personality Disorder

October 1, 2024
·
11 min read
Press Releases

Sagimet Receives FDA Breakthrough Therapy Designation for Denifanstat in MASH

October 1, 2024
·
6 min read
Press Releases

PolyPid Announces Last Patient In for Planned Unblinded Interim Analysis in the Ongoing SHIELD II Phase 3 Trial Evaluating D-PLEX₁₀₀ for the Prevention of Abdominal Colorectal Surgical Site Infections

October 1, 2024
·
6 min read
Press Releases

Chemomab Therapeutics to Present at October 2024 Investor Conferences

October 1, 2024
·
2 min read
Press Releases

CAMP4 Enters Strategic Research Collaboration to Advance Novel Regulatory RNA-Targeting Medicines for Rare Genetic Conditions

October 1, 2024
·
2 min read
Press Releases

EDAP Announces First Patients Treated in Phase I/II Study Evaluating Focal One Robotic HIFU for the Treatment of Benign Prostatic Hyperplasia (BPH)

October 1, 2024
·
5 min read